News
CELZ
2.000
+1.52%
0.030
Creative Medical Technology Expands ADAPT Trial After New FDA Clearance
NASDAQ · 2d ago
Creative Medical expands ADAPT trial under new FDA clearance
TipRanks · 2d ago
Creative Medical Technology Receives FDA Clearance To Expand Its ADAPT Clinical Trial Evaluating CELZ-201 For Chronic Lower Back Pain Associated With Degenerative Disc Disease
Benzinga · 2d ago
Creative Medical wins FDA clearance to expand ADAPT trial of Olastrocel in chronic lower back pain
PUBT · 2d ago
CREATIVE MEDICAL TECHNOLOGY HOLDINGS EXPANDS ADAPT TRIAL UNDER NEW FDA CLEARANCE AND RAPIDLY ADVANCES TOWARD PHASE 3 PLANNING FOR OLASTROCEL IN CHRONIC LOWER BACK PAIN
Reuters · 2d ago
Weekly Report: what happened at CELZ last week (0615-0619)?
Weekly Report · 3d ago
Creative Medical Technology Advances Project PHOENIX Into National Wide AI-Driven Data Collection
NASDAQ · 06/16 14:03
Creative Medical launches national veteran data collection for Project PHOENIX
TipRanks · 06/16 13:30
Creative Medical advances Project PHOENIX burn pit exposure registry into nationwide AI-driven virtual data collection phase
PUBT · 06/16 13:04
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 06/15 21:05
Weekly Report: what happened at CELZ last week (0608-0612)?
Weekly Report · 06/15 10:12
Weekly Report: what happened at CELZ last week (0601-0605)?
Weekly Report · 06/08 10:08
Weekly Report: what happened at CELZ last week (0525-0529)?
Weekly Report · 06/01 10:12
Weekly Report: what happened at CELZ last week (0518-0522)?
Weekly Report · 05/25 10:15
Weekly Report: what happened at CELZ last week (0511-0515)?
Weekly Report · 05/18 10:15
Weekly Report: what happened at CELZ last week (0504-0508)?
Weekly Report · 05/11 10:12
Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate
Benzinga · 05/08 22:12
Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26
PUBT · 05/08 20:46
Weekly Report: what happened at CELZ last week (0427-0501)?
Weekly Report · 05/04 10:10
Creative Medical knee data ‘highly positive,’ says Roth Capital
TipRanks · 04/28 15:53
More
Webull provides a variety of real-time CELZ stock news. You can receive the latest news about Creative Med Technology Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.